INFU

SEC source: 0001445866-17-001762 · form4.xml · nonDerivative · entry 1

Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner

Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner

TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner

BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner

BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,063,652

F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

F3 · ownership.direct: As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock.

SEC source: 0001445866-17-001749 · form4.xml · nonDerivative · entry 3

Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner

Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner

TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner

BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner

BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,051,652

F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

SEC source: 0001445866-17-001749 · form4.xml · nonDerivative · entry 2

Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner

Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner

TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner

BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner

BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,049,852

F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

SEC source: 0001445866-17-001749 · form4.xml · nonDerivative · entry 1

Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner

Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner

TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner

BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner

BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,034,852

F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

SEC source: 0001014108-17-000199 · primary_doc.xml · nonDerivative · entry 2

Sansone Christopher R. · CIK 0001519525 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 276,138

F2 · ownership.direct: The reported securities are directly owned by Sansone Partners (QP), L.P.

SEC source: 0001014108-17-000199 · primary_doc.xml · nonDerivative · entry 1

Sansone Christopher R. · CIK 0001519525 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,310,012

F1 · ownership.direct: The reported securities are directly owned by Sansone Partners, L.P.

SEC source: 0001014108-17-000197 · primary_doc.xml · nonDerivative · entry 2

Sansone Christopher R. · CIK 0001519525 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 267,886

F2 · ownership.direct: The reported securities are directly owned by Sansone Partners (QP), L.P.

SEC source: 0001014108-17-000197 · primary_doc.xml · nonDerivative · entry 1

Sansone Christopher R. · CIK 0001519525 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,277,004

F1 · ownership.direct: The reported securities are directly owned by Sansone Partners, L.P.

SEC source: 0001014108-17-000196 · primary_doc.xml · nonDerivative · entry 2

Sansone Christopher R. · CIK 0001519525 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 267,486

F2 · ownership.direct: The reported securities are directly owned by Sansone Partners (QP), L.P., a Delaware limited partnership.

SEC source: 0001014108-17-000196 · primary_doc.xml · nonDerivative · entry 1

Sansone Christopher R. · CIK 0001519525 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,275,404

F1 · ownership.direct: The reported securities are directly owned by Sansone Partners, L.P., a Delaware limited partnership.

SEC source: 0001014108-17-000195 · primary_doc.xml · nonDerivative · entry 4

Sansone Christopher R. · CIK 0001519525 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 266,486

F2 · ownership.direct: The reported securities are directly owned by Sansone Partners (QP), L.P., a Delaware limited partnership.

SEC source: 0001014108-17-000195 · primary_doc.xml · nonDerivative · entry 3

Sansone Christopher R. · CIK 0001519525 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,271,406

F1 · ownership.direct: The reported securities are directly owned by Sansone Partners, L.P., a Delaware limited partnership.

SEC source: 0001014108-18-000123 · primary_doc.xml · nonDerivative · entry 5

Sansone Christopher R. · CIK 0001519525 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See

Disclosed balance after: 266,486

F1 · ownership.nature: In the Reporting Person's Form 4 report filed with the Commission on November 22, 2017, and in each of the four Form 4 reports filed by the Reporting Person subsequent to that November 22, 2017 Form 4 filing, the Reporting Person mistakenly reported the securities owned by Sansone Partners, L.P. (see footnote 2 below) and by Sansone Partners (QP), L.P. (see footnote 3 below) as being owned by him directly in addition to also being reported as being owned by him indirectly. That November 22, 2017 Form 4 filing, and the four subsequent Form 4 filings, are amended to clarify that the Reporting Person owned no shares directly and to correctly report the actual indirect ownership of shares and thereby eliminates the duplicative reporting of shares.

F3 · ownership.nature: The reported securities are directly owned by Sansone Partners (QP), L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001014108-18-000123 · primary_doc.xml · nonDerivative · entry 3

Sansone Christopher R. · CIK 0001519525 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See

Disclosed balance after: 1,271,406

F1 · ownership.nature: In the Reporting Person's Form 4 report filed with the Commission on November 22, 2017, and in each of the four Form 4 reports filed by the Reporting Person subsequent to that November 22, 2017 Form 4 filing, the Reporting Person mistakenly reported the securities owned by Sansone Partners, L.P. (see footnote 2 below) and by Sansone Partners (QP), L.P. (see footnote 3 below) as being owned by him directly in addition to also being reported as being owned by him indirectly. That November 22, 2017 Form 4 filing, and the four subsequent Form 4 filings, are amended to clarify that the Reporting Person owned no shares directly and to correctly report the actual indirect ownership of shares and thereby eliminates the duplicative reporting of shares.

F2 · ownership.nature: The reported securities are directly owned by Sansone Partners, L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001014108-17-000195 · primary_doc.xml · nonDerivative · entry 2

Sansone Christopher R. · CIK 0001519525 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 262,654

F2 · ownership.direct: The reported securities are directly owned by Sansone Partners (QP), L.P., a Delaware limited partnership.

SEC source: 0001014108-17-000195 · primary_doc.xml · nonDerivative · entry 1

Sansone Christopher R. · CIK 0001519525 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,256,079

F1 · ownership.direct: The reported securities are directly owned by Sansone Partners, L.P., a Delaware limited partnership.

SEC source: 0001014108-18-000123 · primary_doc.xml · nonDerivative · entry 4

Sansone Christopher R. · CIK 0001519525 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See

Disclosed balance after: 262,654

F1 · ownership.nature: In the Reporting Person's Form 4 report filed with the Commission on November 22, 2017, and in each of the four Form 4 reports filed by the Reporting Person subsequent to that November 22, 2017 Form 4 filing, the Reporting Person mistakenly reported the securities owned by Sansone Partners, L.P. (see footnote 2 below) and by Sansone Partners (QP), L.P. (see footnote 3 below) as being owned by him directly in addition to also being reported as being owned by him indirectly. That November 22, 2017 Form 4 filing, and the four subsequent Form 4 filings, are amended to clarify that the Reporting Person owned no shares directly and to correctly report the actual indirect ownership of shares and thereby eliminates the duplicative reporting of shares.

F3 · ownership.nature: The reported securities are directly owned by Sansone Partners (QP), L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001014108-18-000123 · primary_doc.xml · nonDerivative · entry 2

Sansone Christopher R. · CIK 0001519525 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See

Disclosed balance after: 1,256,079

F1 · ownership.nature: In the Reporting Person's Form 4 report filed with the Commission on November 22, 2017, and in each of the four Form 4 reports filed by the Reporting Person subsequent to that November 22, 2017 Form 4 filing, the Reporting Person mistakenly reported the securities owned by Sansone Partners, L.P. (see footnote 2 below) and by Sansone Partners (QP), L.P. (see footnote 3 below) as being owned by him directly in addition to also being reported as being owned by him indirectly. That November 22, 2017 Form 4 filing, and the four subsequent Form 4 filings, are amended to clarify that the Reporting Person owned no shares directly and to correctly report the actual indirect ownership of shares and thereby eliminates the duplicative reporting of shares.

F2 · ownership.nature: The reported securities are directly owned by Sansone Partners, L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

SEC source: 0001014108-17-000205 · primary_doc.xml · derivative · entry 8

Dilorio Richard · CIK 0001706994 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2022-11-15

F7 · derivative.exercise_date: The option, representing the right to purchase a total of 200,000 shares of InfuSystem Holdings, Inc. common stock, vests over four-year period on a monthly basis beginning December 15, 2017.

SEC source: 0001014108-17-000205 · primary_doc.xml · derivative · entry 7

Dilorio Richard · CIK 0001706994 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2019-03-31

F6 · derivative.exercise_date: The stock appreciation rights shall vest and become exercisable beginning on December 31, 2018, based on certain company financial criteria.

SEC source: 0001445866-17-001315 · form4.xml · nonDerivative · entry 2

Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner

Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner

TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner

BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner

BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,027,552

F2 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

SEC source: 0001445866-17-001315 · form4.xml · nonDerivative · entry 1

Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner

Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner

TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner

BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner

BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,022,570

F1 · ownership.direct: These securities are owned by Meridian TSV II, LP.

SEC source: 0001445866-17-001311 · form4.xml · nonDerivative · entry 1

Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner

Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner

TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner

BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner

BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,007,570

F1 · ownership.direct: These securities are owned by Meridian TSV II, LP., and were acquired coincident to a subscription by a new limited partner to such entity. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock.

SEC source: 0001014108-17-000152 · primary_doc.xml · derivative · entry 1

Smith Trent N. · CIK 0001705689 · Exec VP,CAO & Corp Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2022-09-07

F1 · derivative.exercise_date: The option, representing the right to purchase a total of 25,000 shares of InfuSystem Holdings, Inc. common stock, vests annually over three years beginning September 7, 2018.

SEC source: 0001014108-17-000151 · primary_doc.xml · derivative · entry 1

Downs Christopher · CIK 0001705978 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2022-09-07

F1 · derivative.exercise_date: The option, representing the right to purchase a total of 25,000 shares of InfuSystem Holdings, Inc. common stock, vests annually over three years beginning September 7, 2018.

SEC source: 0001014108-17-000156 · primary_doc.xml · derivative · entry 1

Shuda Scott · CIK 0001486636 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2022-09-07

F1 · derivative.exercise_date: The option, representing the right to purchase a total of 25,000 shares of InfuSystem Holdings, Inc. common stock, vests in twelve monthly installments beginning October 7, 2017.

SEC source: 0001014108-17-000149 · primary_doc.xml · derivative · entry 1

Skonieczny Janet · CIK 0001418854 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2022-09-07

F1 · derivative.exercise_date: The option, representing the right to purchase a total of 25,000 shares of InfuSystem Holdings, Inc. common stock, vests annually over three years beginning October 7, 2018.

SEC source: 0001014108-17-000154 · primary_doc.xml · derivative · entry 1

WHITTERS JOSEPH E · CIK 0001186680 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2022-09-07

F1 · derivative.exercise_date: The option, representing the right to purchase a total of 25,000 shares of InfuSystem Holdings, Inc. common stock, vests in twelve monthly installments beginning October 7, 2017.

SEC source: 0001014108-17-000155 · primary_doc.xml · derivative · entry 1

DREYER DAVID C · CIK 0001203607 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2022-09-07

F1 · derivative.exercise_date: The option, representing the right to purchase a total of 25,000 shares of InfuSystem Holdings, Inc. common stock, vests in twelve monthly installments beginning October 7, 2017.

SEC source: 0001014108-17-000157 · primary_doc.xml · derivative · entry 1

Montgomery Darrell B · CIK 0001639250 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2022-09-07

F1 · derivative.exercise_date: The option, representing the right to purchase a total of 25,000 shares of InfuSystem Holdings, Inc. common stock, vests in twelve monthly installments beginning October 7, 2017.

SEC source: 0001014108-17-000153 · primary_doc.xml · derivative · entry 1

Lehman Gregg Owen · CIK 0001376620 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2022-09-07

F1 · derivative.exercise_date: The option, representing the right to purchase a total of 60,000 shares of InfuSystem Holdings, Inc. common stock, vests in twelve monthly installments beginning October 7, 2017.

SEC source: 0001014108-17-000150 · primary_doc.xml · derivative · entry 1

Dilorio Richard · CIK 0001706994 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2022-09-07

F1 · derivative.exercise_date: The option, representing the right to purchase a total of 25,000 shares of InfuSystem Holdings, Inc. common stock, vests annually over three years beginning September 7, 2018.

SEC source: 0001014108-17-000159 · primary_doc.xml · derivative · entry 1

Sansone Christopher R. · CIK 0001519525 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2022-09-07

F1 · derivative.exercise_date: The option, representing the right to purchase a total of 25,000 shares of InfuSystem Holdings, Inc. common stock, vests in twelve monthly installments beginning October 7, 2017.

SEC source: 0001445866-17-001281 · form4.xml · nonDerivative · entry 3

Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner

Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner

TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner

BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner

BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,782,570

F2 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

SEC source: 0001445866-17-001281 · form4.xml · nonDerivative · entry 2

Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner

Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner

TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner

BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner

BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,781,970

F2 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

SEC source: 0001445866-17-001281 · form4.xml · nonDerivative · entry 1

Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner

Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner

TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner

BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner

BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,781,670

F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP.

SEC source: 0001445866-17-001277 · form4.xml · nonDerivative · entry 3

Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner

Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner

TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner

BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner

BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,751,670

F1 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

SEC source: 0001445866-17-001277 · form4.xml · nonDerivative · entry 2

Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner

Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner

TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner

BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner

BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,740,610

F1 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

SEC source: 0001445866-17-001277 · form4.xml · nonDerivative · entry 1

Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner

Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner

TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner

BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner

BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,740,455

F1 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

SEC source: 0001445866-17-001234 · form4.xml · nonDerivative · entry 3

Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner

Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner

TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner

BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner

BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,738,289

F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

SEC source: 0001445866-17-001234 · form4.xml · nonDerivative · entry 2

Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner

Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner

TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner

BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner

BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,711,619

F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

SEC source: 0001014108-17-000132 · primary_doc.xml · nonDerivative · entry 1

Dilorio Richard · CIK 0001706994 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,659

SEC source: 0001014108-17-000135 · primary_doc.xml · nonDerivative · entry 1

Downs Christopher · CIK 0001705978 · CFO (interim)

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,840

SEC source: 0001445866-17-001234 · form4.xml · nonDerivative · entry 1

Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner

Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner

TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner

BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner

BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,696,619

F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

SEC source: 0001014108-17-000134 · primary_doc.xml · nonDerivative · entry 2

Montgomery Darrell B · CIK 0001639250 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

SEC source: 0001014108-17-000134 · primary_doc.xml · nonDerivative · entry 1

Montgomery Darrell B · CIK 0001639250 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,000

SEC source: 0001445866-17-000838 · form4.xml · nonDerivative · entry 2

Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner

Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner

TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner

BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner

BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,681,619

F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

SEC source: 0001445866-17-000838 · form4.xml · nonDerivative · entry 1

Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner

Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner

TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner

BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner

BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,681,510

F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

SEC source: 0001445866-17-000809 · form4.xml · nonDerivative · entry 2

Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner

Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner

TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner

BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner

BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,671,510

F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

SEC source: 0001445866-17-000809 · form4.xml · nonDerivative · entry 1

Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner

Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner

TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner

BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner

BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,671,410

F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.